⌘K

Home/Filings/4/0001209191-22-056826

4//SEC Filing

Holtzman Douglas 4

Accession 0001209191-22-056826

CIK 0001786255other

View on SEC.gov Company Profile

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 6:58 PM ET

Size

5.4 KB

Accession

0001209191-22-056826

Insider Transaction Report

Form 4

Period: 2022-11-10

Icosavax, Inc.ICVX

Holtzman Douglas

Chief Scientific Officer

Transactions

Award
Stock Option (Right to Buy)
2022-11-10+82,580→ 82,580 total
Exercise: $2.47Exp: 2032-11-09→ Common Stock (82,580 underlying)

Footnotes (1)

[F1]One-third (1/3rd) of the shares subject to the option shall vest on each of the first three anniversaries of November 10, 2022, subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Icosavax, Inc.

CIK 0001786255

Entity typeother

Related Parties

1

filerCIK 0001874371

Filing Metadata

Form type: 4
Filed: Nov 13, 7:00 PM ET
Accepted: Nov 14, 6:58 PM ET
Size: 5.4 KB

View on SEC.gov